These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10557868)

  • 1. "Home brew" laboratory tests.
    Kisner HJ
    Clin Lab Manage Rev; 1999; 13(2):104-6. PubMed ID: 10557868
    [No Abstract]   [Full Text] [Related]  

  • 2. Coping with the IVD directive.
    Gower G
    Med Device Technol; 2000 Oct; 11(8):28-9. PubMed ID: 11185185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Understanding US labelling requirements.
    Donawa M
    Med Device Technol; 2005 Sep; 16(7):21-3. PubMed ID: 16259155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Home-brew tests need regulation.
    Nature; 2014 Aug; 512(7512):5. PubMed ID: 25100448
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmaceuticals and medical devices: medical devices. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2012 Dec; ():1-35. PubMed ID: 23297445
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA's proposed regulatory approach to regulation of hematopoietic stem/progenitor cell products.
    Harvath L
    Cytotherapy; 1999; 1(4):358-9. PubMed ID: 20440912
    [No Abstract]   [Full Text] [Related]  

  • 7. Differing definitions of manufacturer.
    Donawa ME
    Med Device Technol; 1998; 9(6):14-7. PubMed ID: 10182120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA pilot programme in support of global harmonisation.
    Donawa ME
    Med Device Technol; 2003 Nov; 14(9):32-4. PubMed ID: 14682021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organising European technical documentation to avoid duplication.
    Donawa M
    Med Device Technol; 2006 Apr; 17(3):29-31. PubMed ID: 16736662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keeping waived tests simple.
    Clin Leadersh Manag Rev; 2004; 18(1):65-9. PubMed ID: 14968759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. News from the latest CLIAC meeting.
    Pontius CA
    MLO Med Lab Obs; 2001 Jul; 33(7):38-40. PubMed ID: 11467173
    [No Abstract]   [Full Text] [Related]  

  • 12. How FDA-recognized standards impact users, manufacturers.
    Osborn D
    Biomed Instrum Technol; 2009; 43(2):156-7. PubMed ID: 19480488
    [No Abstract]   [Full Text] [Related]  

  • 13. Coping with CLIA, Part 7. Walking the straight and narrow on quality control.
    Passey RB
    MLO Med Lab Obs; 1993 Feb; 25(2):39-43. PubMed ID: 10171371
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA weighing feasibility of at-home testing for AIDS virus.
    AIDS Read; 2005 Nov; 15(11):574. PubMed ID: 16331828
    [No Abstract]   [Full Text] [Related]  

  • 15. Standards struggle. Suppliers question push for lone device ID system.
    Rhea S
    Mod Healthc; 2010 Jul; 40(28):10. PubMed ID: 20669379
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA announces final rule establishing UDI system for medical devices.
    Health Devices; 2013 Nov; 42(11):383. PubMed ID: 24358514
    [No Abstract]   [Full Text] [Related]  

  • 17. FDA and CLIA oversight of advanced diagnostics and biomarker tests.
    Terry SF
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):285-7. PubMed ID: 20578940
    [No Abstract]   [Full Text] [Related]  

  • 18. Tagging the issues surrounding auto-ID labels.
    Sparnon E
    Biomed Instrum Technol; 2006; Suppl():25-6. PubMed ID: 16596846
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA ignores CLIA and moves to regulate clinical laboratories.
    Killingsworth LM
    Clin Chem; 1993 Feb; 39(2):179-80. PubMed ID: 8432005
    [No Abstract]   [Full Text] [Related]  

  • 20. US Food and Drug Administration proposes federal regulation of labeling of latex-containing medical devices.
    Kedas AM; Dillard S; Tomazic V
    AORN J; 1996 Aug; 64(2):290-2. PubMed ID: 8853787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.